TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Avia Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
200,504
|
224,672
|
217,258 |
| Financial expenses |
74,992
|
38,827
|
30,442 |
| Earnings before taxes |
-15,048
|
-9,909
|
19,084 |
| EBITDA |
8,056
|
12,605
|
30,996 |
| Total assets |
778,857
|
497,966
|
503,112 |
| Current assets |
111,889
|
113,515
|
124,939 |
| Current liabilities |
45,687
|
49,554
|
59,671 |
| Equity capital |
157,921
|
88,033
|
68,474 |
| - share capital |
300
|
300
|
300 |
| Employees (average) |
11
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.3%
|
17.7%
|
13.6% |
| Turnover per employee |
18,228
|
28,084
|
31,037 |
| Profit as a percentage of turnover |
-7.5%
|
-4.4%
|
8.8% |
| Return on assets (ROA) |
7.7%
|
5.8%
|
9.8% |
| Current ratio |
244.9%
|
229.1%
|
209.4% |
| Return on equity (ROE) |
-9.5%
|
-11.3%
|
27.9% |
| Change turnover |
-24,168
|
7,414
|
19,026 |
| Change turnover % |
-11%
|
3%
|
10% |
| Chg. No. of employees |
3
|
1
|
1 |
| Chg. No. of employees % |
38%
|
14%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.